Novo-Nordisk A/S
NVO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
$NVO is featured in our Tom Carper strategy.
See All StrategiesIncome
Balance Sheet
Cash Flow
NVO Income Statement
NVO Balance Sheet
NVO Cash Flow
Recent trades of NVO by members of U.S. Congress
NVO Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
NVO Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
NVO Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NVO's directors and management
Government lobbying spending instances
-
$780,000 Oct 18, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
-
$1,060,000 Jul 19, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
-
$1,490,000 Apr 18, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
-
$2,180,000 Apr 18, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
-
$60,000 Feb 07, 2024 Issue: Budget/Appropriations Pharmacy Medicare/Medicaid Health Issues
-
$600,000 Oct 19, 2023 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Prodrugs and uses thereof Dec. 12, 2023
-
Patent Title: Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid Dec. 05, 2023
-
Patent Title: Apoc-ii mimetic peptides Nov. 28, 2023
-
Patent Title: Factor x binders enhancing fx activation Oct. 17, 2023
-
Patent Title: Dchbs-active esters of peg compounds and their use Oct. 17, 2023
-
Patent Title: Anti-angptl3 antibodies suitable for high concentration compositions and subcutaneous administration Oct. 10, 2023
-
Patent Title: Co-agonists at glp-1 and gip receptors suitable for oral delivery Oct. 10, 2023
-
Patent Title: Glucose-sensitive albumin-binding derivatives Sep. 26, 2023
-
Patent Title: Accessory device with mounting feature for engaging dial member Sep. 19, 2023
-
Patent Title: Compositions of glp-1 peptides and preparation thereof Sep. 19, 2023
-
Patent Title: Compositions of glp-1 peptides and preparation thereof Sep. 19, 2023
-
Patent Title: Compositions of glp-1 peptides and preparation thereof Sep. 19, 2023
-
Patent Title: Compounds for treatment of obesity Sep. 12, 2023
-
Patent Title: Glp-1 compositions and uses thereof Sep. 12, 2023
-
Patent Title: Selective elimination of erosive cells Jul. 11, 2023
-
Patent Title: Drug delivery system with multipolar magnet and sensor system Jun. 27, 2023
-
Patent Title: Method for using insulin degludec for the improvement of glycemic control and reduction of acute and long-term diabetes complications Jun. 13, 2023
-
Patent Title: Cartridge holder assembly for drug delivery device Jun. 13, 2023
-
Patent Title: Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (marc1) expression May. 23, 2023
-
Patent Title: Bifunctional compounds comprising insulin peptides and egf(a) peptides May. 16, 2023
-
Patent Title: Power unit for drug delivery device May. 16, 2023
-
Patent Title: Spring straining mechanism for torsion spring based device Apr. 25, 2023
-
Patent Title: Gip derivatives and uses thereof Apr. 25, 2023
-
Patent Title: Systems and methods for optimization of bolus timing relative to meal events Apr. 18, 2023
-
Patent Title: Anti-transthyretin antibodies Apr. 18, 2023
-
Patent Title: Plunger sub-assembly for a prefilled medicament injector, a prefilled medicament injector and method for assembling a prefilled medical injector Apr. 18, 2023
-
Patent Title: Dose capturing assembly with secondary image analysis feature Apr. 11, 2023
-
Patent Title: Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid Apr. 11, 2023
-
Patent Title: Process of spray drying of glp-1 peptide Apr. 04, 2023
-
Patent Title: Accessory device for drug delivery device Mar. 07, 2023
-
Patent Title: Logging device for drug delivery device Feb. 28, 2023
-
Patent Title: Compositions and methods for inhibiting nuclear receptor subfamily 1 group h member 3 (nr1h3) expression Feb. 14, 2023
-
Patent Title: Glp-1 derivatives and uses thereof Feb. 07, 2023
-
Patent Title: Systems and methods for analysis of insulin regimen adherence data Jan. 24, 2023
-
Patent Title: Rotary dosage sensing module for and in a disposable pen drug delivery device Dec. 27, 2022
-
Patent Title: Systems and methods for the determination of insulin sensitivity Dec. 06, 2022
-
Patent Title: Double-acylated glp-1 derivatives Dec. 06, 2022
-
Patent Title: Prefilled drug delivery device with reduced air gap Nov. 29, 2022
-
Patent Title: Insulin analogues and uses thereof Nov. 15, 2022
-
Patent Title: Needle unit with floating needle hub Nov. 08, 2022
-
Patent Title: Semaglutide for use in medicine Oct. 25, 2022
-
Patent Title: Oligomer extended insulin-fc conjugates Oct. 18, 2022
-
Patent Title: Temperature based plasmid regulation system Oct. 11, 2022
-
Patent Title: Stabilised protein solutions Oct. 11, 2022
-
Patent Title: Drug delivery device with zero position adjustment feature Oct. 11, 2022
-
Patent Title: Regimen adherence measure for insulin treatment based on glucose measurements and insulin pen data Oct. 11, 2022
-
Patent Title: Systems and methods for adjusting a basal/bolus ratio in an insulin regimen Oct. 04, 2022
-
Patent Title: Drug delivery device with slim drive mechanism Oct. 04, 2022
-
Patent Title: Injection device with torsion spring and rotatable display Sep. 20, 2022
-
Patent Title: Flow communication unit with preservative Sep. 13, 2022
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of NVO in WallStreetBets Daily Discussion
NVO News
Recent insights relating to NVO
CNBC Recommendations
Recent picks made for NVO stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NVO
NVO Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
NVO Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NVO Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More